TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner
Genes · 26.02.2023 · 14 (3) · 591
DOI: 10.3390/genes14030591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 26.02.2023. Verfasst von Hao Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: Heart Injuries, Methyltransferases, Myocardial Infarction, Tenascin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Research Plan of the National Natural Science Foundation of China, Nation Natural Science Foundation of China.
Abstract (Originalsprache)
Cardiac fibrosis and cardiomyocyte apoptosis are reparative processes after myocardial infarction (MI), which results in cardiac remodeling and heart failure at last. Tenascin-C (TNC) consists of four distinct domains, which is a large multimodular glycoprotein of the extracellular matrix. It is also a key regulator of proliferation and apoptosis in cardiomyocytes. As a significant m6A regulator, METTL3 binds m6A sites in mRNA to control its degradation, maturation, stabilization, and translation. Whether METTL3 regulates the occurrence and development of myocardial infarction through the m6A modification of TNC mRNA deserves our study. Here, we have demonstrated that overexpression of METTL3 aggravated cardiac dysfunction and cardiac fibrosis after 4 weeks after MI. Moreover, we also demonstrated that TNC resulted in cardiac fibrosis and cardiomyocyte apoptosis after MI. Mechanistically, METTL3 led to enhanced m6A levels of TNC mRNA and promoted TNC mRNA stability. Then, we mutated one m6A site “A” to “T”, and the binding ability of METTL3 was reduced. In conclusion, METTL3 is involved in cardiac fibrosis and cardiomyocyte apoptosis by increasing m6A levels of TNC mRNA and may be a promising target for the therapy of cardiac fibrosis after MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China.
ORCID-Profile: Hao Cheng
Förderung
- Major Research Plan of the National Natural Science Foundation of China
- Nation Natural Science Foundation of China
Zitieren
APA
Cheng, H., Li, L., Xue, J., Ma, J., & Ge, J. (2023). TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner. Genes, 14(3), 591. https://doi.org/10.3390/genes14030591
Vancouver
Cheng H, Li L, Xue J, Ma J, Ge J. TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner. Genes. 2023;14(3):591. doi:10.3390/genes14030591
BibTeX
@article{Cheng2023,
author = {Cheng, Hao and Li, Linnan and Xue, Junqiang and Ma, Jianying and Ge, Junbo},
title = {TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner},
journal = {Genes},
year = {2023},
volume = {14},
number = {3},
pages = {591},
doi = {10.3390/genes14030591}
}
EUVIMED